

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.79346178 |
| 2 | regulation of response to osmotic stress (GO:0047484) | 5.10645315 |
| 3 | maintenance of protein location in nucleus (GO:0051457) | 4.70904526 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.70010996 |
| 5 | response to dietary excess (GO:0002021) | 4.53270519 |
| 6 | glomerular visceral epithelial cell development (GO:0072015) | 4.08193103 |
| 7 | cellular modified amino acid catabolic process (GO:0042219) | 4.06511024 |
| 8 | hormone catabolic process (GO:0042447) | 4.05356167 |
| 9 | neuronal ion channel clustering (GO:0045161) | 4.04620100 |
| 10 | proline transport (GO:0015824) | 4.01802077 |
| 11 | somite rostral/caudal axis specification (GO:0032525) | 4.01651657 |
| 12 | negative regulation of telomerase activity (GO:0051974) | 4.00723382 |
| 13 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.96826954 |
| 14 | positive regulation of histone deacetylation (GO:0031065) | 3.89429953 |
| 15 | glomerular basement membrane development (GO:0032836) | 3.72619743 |
| 16 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.71311664 |
| 17 | phagocytosis, recognition (GO:0006910) | 3.70630087 |
| 18 | glomerular epithelial cell development (GO:0072310) | 3.69167247 |
| 19 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.68036566 |
| 20 | negative regulation of epidermis development (GO:0045683) | 3.66742764 |
| 21 | biotin metabolic process (GO:0006768) | 3.60479316 |
| 22 | coenzyme catabolic process (GO:0009109) | 3.54997990 |
| 23 | phenol-containing compound catabolic process (GO:0019336) | 3.50626303 |
| 24 | cytidine metabolic process (GO:0046087) | 3.47618303 |
| 25 | cytidine catabolic process (GO:0006216) | 3.47618303 |
| 26 | cytidine deamination (GO:0009972) | 3.47618303 |
| 27 | cardiovascular system development (GO:0072358) | 3.47373813 |
| 28 | central nervous system myelination (GO:0022010) | 3.46801745 |
| 29 | axon ensheathment in central nervous system (GO:0032291) | 3.46801745 |
| 30 | histone H4-K8 acetylation (GO:0043982) | 3.41505190 |
| 31 | histone H4-K5 acetylation (GO:0043981) | 3.41505190 |
| 32 | activation of protein kinase A activity (GO:0034199) | 3.38883788 |
| 33 | glutamate secretion (GO:0014047) | 3.36291158 |
| 34 | positive regulation of protein deacetylation (GO:0090312) | 3.35761134 |
| 35 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.33753501 |
| 36 | synaptic vesicle exocytosis (GO:0016079) | 3.32985438 |
| 37 | cellular potassium ion homeostasis (GO:0030007) | 3.29356154 |
| 38 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.27198073 |
| 39 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.24720153 |
| 40 | mitochondrion distribution (GO:0048311) | 3.24053427 |
| 41 | L-amino acid import (GO:0043092) | 3.19210657 |
| 42 | positive regulation of digestive system process (GO:0060456) | 3.18669650 |
| 43 | cGMP-mediated signaling (GO:0019934) | 3.17490875 |
| 44 | muscle organ morphogenesis (GO:0048644) | 3.15733313 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.14681746 |
| 46 | cell volume homeostasis (GO:0006884) | 3.12256046 |
| 47 | barbed-end actin filament capping (GO:0051016) | 3.12029664 |
| 48 | regulation of synapse maturation (GO:0090128) | 3.09720245 |
| 49 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.09717976 |
| 50 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.08619513 |
| 51 | notochord development (GO:0030903) | 3.05122319 |
| 52 | positive regulation of macrophage cytokine production (GO:0060907) | 3.00797015 |
| 53 | cellular response to cholesterol (GO:0071397) | 2.99833966 |
| 54 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.99098551 |
| 55 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.97592793 |
| 56 | quinone metabolic process (GO:1901661) | 2.97496014 |
| 57 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.96041514 |
| 58 | triglyceride catabolic process (GO:0019433) | 2.95894405 |
| 59 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.92818901 |
| 60 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.92815134 |
| 61 | cellular response to epinephrine stimulus (GO:0071872) | 2.91040043 |
| 62 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.89998389 |
| 63 | positive regulation of synapse maturation (GO:0090129) | 2.89581118 |
| 64 | transepithelial transport (GO:0070633) | 2.88637608 |
| 65 | ovulation cycle (GO:0042698) | 2.85542585 |
| 66 | regulation of vascular permeability (GO:0043114) | 2.85521088 |
| 67 | tachykinin receptor signaling pathway (GO:0007217) | 2.84691237 |
| 68 | amino acid import (GO:0043090) | 2.82816995 |
| 69 | blood vessel maturation (GO:0001955) | 2.82382785 |
| 70 | cAMP biosynthetic process (GO:0006171) | 2.80866429 |
| 71 | regulation of ARF protein signal transduction (GO:0032012) | 2.80804825 |
| 72 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.80786168 |
| 73 | nucleoside transmembrane transport (GO:1901642) | 2.80681972 |
| 74 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.78005351 |
| 75 | acylglycerol catabolic process (GO:0046464) | 2.76675270 |
| 76 | neutral lipid catabolic process (GO:0046461) | 2.76675270 |
| 77 | hypotonic response (GO:0006971) | 2.76200557 |
| 78 | synaptic vesicle maturation (GO:0016188) | 2.74786756 |
| 79 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.73265940 |
| 80 | renal filtration (GO:0097205) | 2.73088281 |
| 81 | histone H4-K12 acetylation (GO:0043983) | 2.72852843 |
| 82 | glomerular filtration (GO:0003094) | 2.70600525 |
| 83 | organic cation transport (GO:0015695) | 2.70417428 |
| 84 | histone H4-K16 acetylation (GO:0043984) | 2.69819327 |
| 85 | surfactant homeostasis (GO:0043129) | 2.66867808 |
| 86 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.66138358 |
| 87 | chondroitin sulfate catabolic process (GO:0030207) | 2.65826848 |
| 88 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.65072743 |
| 89 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.64701541 |
| 90 | low-density lipoprotein particle clearance (GO:0034383) | 2.62502105 |
| 91 | alanine transport (GO:0032328) | 2.61945549 |
| 92 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.61154043 |
| 93 | positive regulation of receptor recycling (GO:0001921) | 2.60699734 |
| 94 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.59773388 |
| 95 | interferon-gamma production (GO:0032609) | 2.59413217 |
| 96 | metanephric tubule development (GO:0072170) | 2.59230268 |
| 97 | metanephric nephron tubule development (GO:0072234) | 2.59230268 |
| 98 | cerebellar granule cell differentiation (GO:0021707) | 2.59151359 |
| 99 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.58154909 |
| 100 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.58127819 |
| 101 | endothelial cell chemotaxis (GO:0035767) | 2.55212650 |
| 102 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.55074537 |
| 103 | cellular response to catecholamine stimulus (GO:0071870) | 2.54752081 |
| 104 | cellular response to monoamine stimulus (GO:0071868) | 2.54752081 |
| 105 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.54690028 |
| 106 | cell-substrate junction assembly (GO:0007044) | 2.54032653 |
| 107 | adherens junction assembly (GO:0034333) | 2.52958978 |
| 108 | valine metabolic process (GO:0006573) | 2.52917663 |
| 109 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.52276898 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 2.51946007 |
| 111 | negative regulation of amino acid transport (GO:0051956) | 2.51655542 |
| 112 | semaphorin-plexin signaling pathway (GO:0071526) | 2.51513097 |
| 113 | metanephric nephron epithelium development (GO:0072243) | 2.49274943 |
| 114 | protein targeting to plasma membrane (GO:0072661) | 2.49066994 |
| 115 | apoptotic cell clearance (GO:0043277) | 2.48675758 |
| 116 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.48309297 |
| 117 | sulfur amino acid catabolic process (GO:0000098) | 2.48262499 |
| 118 | primitive streak formation (GO:0090009) | 2.47933352 |
| 119 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.47417080 |
| 120 | vitamin A metabolic process (GO:0006776) | 2.47333220 |
| 121 | cell proliferation involved in metanephros development (GO:0072203) | 2.47253703 |
| 122 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.46655309 |
| 123 | detection of calcium ion (GO:0005513) | 2.46476668 |
| 124 | metanephric epithelium development (GO:0072207) | 2.45810621 |
| 125 | epoxygenase P450 pathway (GO:0019373) | 2.45611667 |
| 126 | locomotory exploration behavior (GO:0035641) | 2.44739531 |
| 127 | potassium ion import (GO:0010107) | 2.44439974 |
| 128 | positive regulation of glucose import (GO:0046326) | 2.44289559 |
| 129 | cell-substrate adherens junction assembly (GO:0007045) | 2.43917530 |
| 130 | focal adhesion assembly (GO:0048041) | 2.43917530 |
| 131 | quaternary ammonium group transport (GO:0015697) | 2.42179385 |
| 132 | regulation of ARF GTPase activity (GO:0032312) | 2.41917018 |
| 133 | neutral amino acid transport (GO:0015804) | 2.41773054 |
| 134 | retinoic acid receptor signaling pathway (GO:0048384) | 2.41755755 |
| 135 | endothelium development (GO:0003158) | 2.41516629 |
| 136 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.41503727 |
| 137 | regulation of cilium movement (GO:0003352) | 2.40967526 |
| 138 | regulation of sequestering of triglyceride (GO:0010889) | 2.40615700 |
| 139 | NADH metabolic process (GO:0006734) | 2.40268657 |
| 140 | cellular response to sterol (GO:0036315) | 2.39965697 |
| 141 | L-serine transport (GO:0015825) | 2.39933835 |
| 142 | cell communication by electrical coupling (GO:0010644) | 2.38743056 |
| 143 | myelin maintenance (GO:0043217) | 2.38477874 |
| 144 | cell communication involved in cardiac conduction (GO:0086065) | 2.38443356 |
| 145 | nucleoside transport (GO:0015858) | 2.37936786 |
| 146 | regulation of synaptic vesicle transport (GO:1902803) | 2.37164054 |
| 147 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.35992150 |
| 148 | neuromuscular process controlling balance (GO:0050885) | 2.34954565 |
| 149 | vocalization behavior (GO:0071625) | 2.34803048 |
| 150 | sulfur compound transport (GO:0072348) | 2.34220800 |
| 151 | extracellular matrix assembly (GO:0085029) | 2.34177971 |
| 152 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.32969360 |
| 153 | cellular response to osmotic stress (GO:0071470) | 2.32761049 |
| 154 | sodium ion export (GO:0071436) | 2.32616454 |
| 155 | mannose metabolic process (GO:0006013) | 2.32265392 |
| 156 | response to epinephrine (GO:0071871) | 2.31749760 |
| 157 | neurotransmitter secretion (GO:0007269) | 2.30917395 |
| 158 | maintenance of protein localization in organelle (GO:0072595) | 2.30337898 |
| 159 | positive regulation of glucose transport (GO:0010828) | 2.29667839 |
| 160 | hemidesmosome assembly (GO:0031581) | 2.29432829 |
| 161 | potassium ion homeostasis (GO:0055075) | 2.29289709 |
| 162 | peripheral nervous system axon ensheathment (GO:0032292) | 2.29097309 |
| 163 | myelination in peripheral nervous system (GO:0022011) | 2.29097309 |
| 164 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.28921134 |
| 165 | regulation of p38MAPK cascade (GO:1900744) | 2.27687964 |
| 166 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.26938128 |
| 167 | actin filament capping (GO:0051693) | 2.26302258 |
| 168 | transcytosis (GO:0045056) | 2.25650850 |
| 169 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.24107637 |
| 170 | glycerolipid catabolic process (GO:0046503) | 2.23425839 |
| 171 | cellular response to reactive nitrogen species (GO:1902170) | 2.22905324 |
| 172 | cardiac muscle contraction (GO:0060048) | 2.22467556 |
| 173 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.22091406 |
| 174 | positive regulation of protein dephosphorylation (GO:0035307) | 2.20594717 |
| 175 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.19915192 |
| 176 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.19147714 |
| 177 | endocrine hormone secretion (GO:0060986) | 2.18083962 |
| 178 | dopamine receptor signaling pathway (GO:0007212) | 2.18054936 |
| 179 | positive regulation of dendritic spine development (GO:0060999) | 2.17955940 |
| 180 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.17525888 |
| 181 | adenosine receptor signaling pathway (GO:0001973) | 2.17339285 |
| 182 | daunorubicin metabolic process (GO:0044597) | 11.3295576 |
| 183 | polyketide metabolic process (GO:0030638) | 11.3295576 |
| 184 | doxorubicin metabolic process (GO:0044598) | 11.3295576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.46987285 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.19751552 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.19751552 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.19751552 |
| 5 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.96232857 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.72898434 |
| 7 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.41089833 |
| 8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35562991 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.16929676 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.05426909 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04287105 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.94002946 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89508944 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.89506452 |
| 15 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.85910380 |
| 16 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.79232489 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78782568 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78782568 |
| 19 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.78131255 |
| 20 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76654333 |
| 21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.74062262 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73112010 |
| 23 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.71623614 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.71056560 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71048261 |
| 26 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.70105254 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69749131 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67233730 |
| 29 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.64116686 |
| 30 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63605832 |
| 31 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.63094377 |
| 32 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.61680308 |
| 33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.60320615 |
| 34 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58408363 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58137515 |
| 36 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.56634148 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56336207 |
| 38 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.52281611 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51726392 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.50189080 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.48111677 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45457083 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45337462 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45216662 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44573181 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42429032 |
| 47 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41322968 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39396391 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38745728 |
| 50 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.38652315 |
| 51 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.37633924 |
| 52 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.35519722 |
| 53 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33217786 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32966978 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30631695 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30627206 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30176102 |
| 58 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.28137973 |
| 59 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28073301 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.27035151 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26414362 |
| 62 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.26408280 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.25190827 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24844465 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24673499 |
| 66 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.22684803 |
| 67 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.22091565 |
| 68 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22066693 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21890174 |
| 70 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.21304194 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21122000 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21008082 |
| 73 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.20412825 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19551421 |
| 75 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.19398934 |
| 76 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19389418 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18801782 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18071726 |
| 79 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16912349 |
| 80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16182966 |
| 81 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15181903 |
| 82 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.14719534 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14712398 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14594142 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12916142 |
| 86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12547449 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11657374 |
| 88 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.11242789 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10840185 |
| 90 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10236292 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10183105 |
| 92 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.10122547 |
| 93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09568428 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09308470 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08285638 |
| 96 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.08112987 |
| 97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08072501 |
| 98 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06891087 |
| 99 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06381456 |
| 100 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05409561 |
| 101 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.05095513 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04790547 |
| 103 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04552358 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03896366 |
| 105 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.03501139 |
| 106 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.02144360 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01965328 |
| 108 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01727078 |
| 109 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01485307 |
| 110 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00700639 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00520311 |
| 112 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00486219 |
| 113 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99527434 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98669600 |
| 115 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.97569931 |
| 116 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97020654 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96975366 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96365297 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96029277 |
| 120 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95813005 |
| 121 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95813005 |
| 122 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95764785 |
| 123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95342176 |
| 124 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94815668 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94364266 |
| 126 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93761113 |
| 127 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92923908 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92532791 |
| 129 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91663659 |
| 130 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91401160 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91356632 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90701553 |
| 133 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90387832 |
| 134 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89890988 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87852754 |
| 136 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.87686859 |
| 137 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87673176 |
| 138 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.86622652 |
| 139 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85901668 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85085888 |
| 141 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84988042 |
| 142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84882781 |
| 143 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83778949 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82514972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.75938218 |
| 2 | MP0004858_abnormal_nervous_system | 3.62358361 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.25206972 |
| 4 | MP0004043_abnormal_pH_regulation | 3.16069671 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 3.10234384 |
| 6 | MP0003011_delayed_dark_adaptation | 2.85613836 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 2.79170136 |
| 8 | MP0003878_abnormal_ear_physiology | 2.79170136 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 2.70983354 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.69364138 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.65188707 |
| 12 | MP0002332_abnormal_exercise_endurance | 2.63090896 |
| 13 | MP0008961_abnormal_basal_metabolism | 2.61350078 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.49419880 |
| 15 | MP0004272_abnormal_basement_membrane | 2.36044127 |
| 16 | MP0003879_abnormal_hair_cell | 2.30990594 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.28147835 |
| 18 | MP0005670_abnormal_white_adipose | 2.15734097 |
| 19 | MP0005623_abnormal_meninges_morphology | 2.14409538 |
| 20 | MP0002127_abnormal_cardiovascular_syste | 2.12241634 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.04947247 |
| 22 | MP0004270_analgesia | 2.02269920 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.01983193 |
| 24 | MP0003137_abnormal_impulse_conducting | 2.01409754 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 1.99890276 |
| 26 | MP0004885_abnormal_endolymph | 1.94514013 |
| 27 | MP0000003_abnormal_adipose_tissue | 1.84692446 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.81878224 |
| 29 | MP0002971_abnormal_brown_adipose | 1.78543609 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.78097025 |
| 31 | MP0003122_maternal_imprinting | 1.75468092 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.68448067 |
| 33 | MP0003329_amyloid_beta_deposits | 1.65597133 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.63745900 |
| 35 | MP0008569_lethality_at_weaning | 1.62157182 |
| 36 | MP0005275_abnormal_skin_tensile | 1.60206517 |
| 37 | MP0001486_abnormal_startle_reflex | 1.60089809 |
| 38 | MP0005499_abnormal_olfactory_system | 1.59040665 |
| 39 | MP0005394_taste/olfaction_phenotype | 1.59040665 |
| 40 | MP0000749_muscle_degeneration | 1.58190559 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.57549609 |
| 42 | MP0001879_abnormal_lymphatic_vessel | 1.54407763 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.53451289 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.52862155 |
| 45 | MP0005409_darkened_coat_color | 1.51362454 |
| 46 | MP0002064_seizures | 1.50695514 |
| 47 | MP0008775_abnormal_heart_ventricle | 1.50689148 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.49471253 |
| 49 | MP0005503_abnormal_tendon_morphology | 1.43453362 |
| 50 | MP0003690_abnormal_glial_cell | 1.42169070 |
| 51 | MP0006138_congestive_heart_failure | 1.40892499 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.40237812 |
| 53 | MP0004036_abnormal_muscle_relaxation | 1.40049574 |
| 54 | MP0000747_muscle_weakness | 1.39645162 |
| 55 | MP0003938_abnormal_ear_development | 1.37107497 |
| 56 | MP0004510_myositis | 1.36585260 |
| 57 | MP0000681_abnormal_thyroid_gland | 1.34471606 |
| 58 | MP0002063_abnormal_learning/memory/cond | 1.34101697 |
| 59 | MP0003279_aneurysm | 1.32737200 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.30903998 |
| 61 | MP0005595_abnormal_vascular_smooth | 1.29230125 |
| 62 | MP0004085_abnormal_heartbeat | 1.29068835 |
| 63 | MP0005535_abnormal_body_temperature | 1.28848819 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.28326600 |
| 65 | MP0001849_ear_inflammation | 1.28309507 |
| 66 | MP0003880_abnormal_central_pattern | 1.28147999 |
| 67 | MP0003303_peritoneal_inflammation | 1.26859047 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.24741303 |
| 69 | MP0002933_joint_inflammation | 1.20952607 |
| 70 | MP0002653_abnormal_ependyma_morphology | 1.19826601 |
| 71 | MP0002108_abnormal_muscle_morphology | 1.19429010 |
| 72 | MP0005330_cardiomyopathy | 1.18973722 |
| 73 | MP0003283_abnormal_digestive_organ | 1.17575051 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.17569881 |
| 75 | MP0003091_abnormal_cell_migration | 1.16279670 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 1.15880578 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.15215265 |
| 78 | MP0003828_pulmonary_edema | 1.14846465 |
| 79 | MP0002972_abnormal_cardiac_muscle | 1.14026332 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 1.12827680 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.12536603 |
| 82 | MP0002249_abnormal_larynx_morphology | 1.11221145 |
| 83 | MP0002272_abnormal_nervous_system | 1.11170047 |
| 84 | MP0005165_increased_susceptibility_to | 1.10111606 |
| 85 | MP0010030_abnormal_orbit_morphology | 1.08966889 |
| 86 | MP0001293_anophthalmia | 1.07602410 |
| 87 | MP0000343_altered_response_to | 1.07289855 |
| 88 | MP0000762_abnormal_tongue_morphology | 1.06490241 |
| 89 | MP0000767_abnormal_smooth_muscle | 1.02056413 |
| 90 | MP0009745_abnormal_behavioral_response | 1.01964002 |
| 91 | MP0002092_abnormal_eye_morphology | 1.01887707 |
| 92 | MP0000049_abnormal_middle_ear | 1.00864020 |
| 93 | MP0002932_abnormal_joint_morphology | 1.00513488 |
| 94 | MP0005332_abnormal_amino_acid | 0.99659895 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.98388277 |
| 96 | MP0002925_abnormal_cardiovascular_devel | 0.98291834 |
| 97 | MP0002269_muscular_atrophy | 0.96346220 |
| 98 | MP0001958_emphysema | 0.95948849 |
| 99 | MP0009046_muscle_twitch | 0.95557888 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.94775340 |
| 101 | MP0008874_decreased_physiological_sensi | 0.94360123 |
| 102 | MP0005620_abnormal_muscle_contractility | 0.93702787 |
| 103 | MP0002572_abnormal_emotion/affect_behav | 0.93559127 |
| 104 | MP0004133_heterotaxia | 0.93166457 |
| 105 | MP0000751_myopathy | 0.93009621 |
| 106 | MP0004087_abnormal_muscle_fiber | 0.92345700 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.92176488 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.91315107 |
| 109 | MP0010630_abnormal_cardiac_muscle | 0.90366579 |
| 110 | MP0000249_abnormal_blood_vessel | 0.89698978 |
| 111 | MP0002133_abnormal_respiratory_system | 0.89624033 |
| 112 | MP0005388_respiratory_system_phenotype | 0.89624033 |
| 113 | MP0004381_abnormal_hair_follicle | 0.89310117 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.89273148 |
| 115 | MP0002970_abnormal_white_adipose | 0.88624599 |
| 116 | MP0008260_abnormal_autophagy | 0.88004745 |
| 117 | MP0005166_decreased_susceptibility_to | 0.86942853 |
| 118 | MP0004484_altered_response_of | 0.86801025 |
| 119 | MP0009115_abnormal_fat_cell | 0.86416735 |
| 120 | MP0002734_abnormal_mechanical_nocicepti | 0.85213376 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.85173219 |
| 122 | MP0000579_abnormal_nail_morphology | 0.84314674 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.84175534 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.82860935 |
| 125 | MP0001177_atelectasis | 0.82676963 |
| 126 | MP0005334_abnormal_fat_pad | 0.82398203 |
| 127 | MP0005023_abnormal_wound_healing | 0.82351109 |
| 128 | MP0003634_abnormal_glial_cell | 0.81918554 |
| 129 | MP0003935_abnormal_craniofacial_develop | 0.81724549 |
| 130 | MP0000733_abnormal_muscle_development | 0.81676745 |
| 131 | MP0003631_nervous_system_phenotype | 0.81210822 |
| 132 | MP0003724_increased_susceptibility_to | 0.81059139 |
| 133 | MP0003959_abnormal_lean_body | 0.79203109 |
| 134 | MP0005369_muscle_phenotype | 0.78601831 |
| 135 | MP0003075_altered_response_to | 0.78133203 |
| 136 | MP0009643_abnormal_urine_homeostasis | 0.78076409 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.77808669 |
| 138 | MP0002733_abnormal_thermal_nociception | 0.77616804 |
| 139 | MP0000920_abnormal_myelination | 0.75391321 |
| 140 | MP0003136_yellow_coat_color | 0.73705418 |
| 141 | MP0003984_embryonic_growth_retardation | 0.72910795 |
| 142 | MP0002233_abnormal_nose_morphology | 0.72879895 |
| 143 | MP0005171_absent_coat_pigmentation | 0.72763620 |
| 144 | MP0002088_abnormal_embryonic_growth/wei | 0.72395115 |
| 145 | MP0002136_abnormal_kidney_physiology | 0.72355173 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.71867042 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.71867042 |
| 148 | MP0008770_decreased_survivor_rate | 0.71800206 |
| 149 | MP0000428_abnormal_craniofacial_morphol | 0.71353325 |
| 150 | MP0002114_abnormal_axial_skeleton | 0.71302860 |
| 151 | MP0002909_abnormal_adrenal_gland | 0.70888534 |
| 152 | MP0001614_abnormal_blood_vessel | 0.70303758 |
| 153 | MP0001270_distended_abdomen | 0.69730185 |
| 154 | MP0003121_genomic_imprinting | 0.69615861 |
| 155 | MP0003633_abnormal_nervous_system | 0.68415350 |
| 156 | MP0003045_fibrosis | 0.68316467 |
| 157 | MP0004130_abnormal_muscle_cell | 0.67982414 |
| 158 | MP0002128_abnormal_blood_circulation | 0.67355096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 5.80256035 |
| 2 | Hepatoblastoma (HP:0002884) | 4.58942414 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 4.11661055 |
| 4 | Obstructive sleep apnea (HP:0002870) | 4.11329691 |
| 5 | Increased circulating renin level (HP:0000848) | 4.10203164 |
| 6 | Difficulty running (HP:0009046) | 3.91296176 |
| 7 | Muscle fiber splitting (HP:0003555) | 3.90419335 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 3.72095127 |
| 9 | Multiple enchondromatosis (HP:0005701) | 3.66936703 |
| 10 | Hypokalemic alkalosis (HP:0001949) | 3.56737215 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.51693080 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.51362114 |
| 13 | Hyperactive renin-angiotensin system (HP:0000841) | 3.50152194 |
| 14 | Metabolic alkalosis (HP:0200114) | 3.48077393 |
| 15 | Lymphangioma (HP:0100764) | 3.32150483 |
| 16 | Partial duplication of thumb phalanx (HP:0009944) | 3.26250339 |
| 17 | Hyperaldosteronism (HP:0000859) | 3.22595595 |
| 18 | Testicular atrophy (HP:0000029) | 3.18492510 |
| 19 | Hyperventilation (HP:0002883) | 3.17354290 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.15461938 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.12040889 |
| 22 | Abnormality of the salivary glands (HP:0010286) | 3.10058954 |
| 23 | Ependymoma (HP:0002888) | 3.08518382 |
| 24 | Gout (HP:0001997) | 3.08069642 |
| 25 | Increased connective tissue (HP:0009025) | 3.07175295 |
| 26 | Ankle clonus (HP:0011448) | 3.03608709 |
| 27 | Exercise-induced myalgia (HP:0003738) | 3.02493829 |
| 28 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.96109479 |
| 29 | Neoplasm of striated muscle (HP:0009728) | 2.95844199 |
| 30 | Pseudobulbar signs (HP:0002200) | 2.95369624 |
| 31 | Distal lower limb amyotrophy (HP:0008944) | 2.93927282 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 2.93185467 |
| 33 | Polyuria (HP:0000103) | 2.91669051 |
| 34 | Myokymia (HP:0002411) | 2.89468590 |
| 35 | Mesangial abnormality (HP:0001966) | 2.87832465 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.87720954 |
| 37 | Rib fusion (HP:0000902) | 2.85786927 |
| 38 | Hypomagnesemia (HP:0002917) | 2.84140044 |
| 39 | Acanthosis nigricans (HP:0000956) | 2.83039516 |
| 40 | Bundle branch block (HP:0011710) | 2.80412347 |
| 41 | Cerebral aneurysm (HP:0004944) | 2.80405524 |
| 42 | Hyperglycinuria (HP:0003108) | 2.78582969 |
| 43 | Abnormal urine output (HP:0012590) | 2.77207672 |
| 44 | Generalized hypotonia (HP:0001290) | 2.76140712 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 2.75972090 |
| 46 | Lower limb amyotrophy (HP:0007210) | 2.72828226 |
| 47 | Axonal loss (HP:0003447) | 2.72475794 |
| 48 | Neoplasm of the heart (HP:0100544) | 2.71822115 |
| 49 | Partial duplication of the phalanx of hand (HP:0009999) | 2.71355489 |
| 50 | Renal salt wasting (HP:0000127) | 2.71331370 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.70163329 |
| 52 | Stridor (HP:0010307) | 2.68870269 |
| 53 | Abnormality of renin-angiotensin system (HP:0000847) | 2.64303008 |
| 54 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.64134131 |
| 55 | Abnormal drinking behavior (HP:0030082) | 2.63626973 |
| 56 | Polydipsia (HP:0001959) | 2.63626973 |
| 57 | Abnormality of renal excretion (HP:0011036) | 2.60833283 |
| 58 | Protrusio acetabuli (HP:0003179) | 2.60191454 |
| 59 | Foot dorsiflexor weakness (HP:0009027) | 2.60009304 |
| 60 | Bronchomalacia (HP:0002780) | 2.59988997 |
| 61 | Visceral angiomatosis (HP:0100761) | 2.59492205 |
| 62 | Anomalous pulmonary venous return (HP:0010772) | 2.55946895 |
| 63 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.55396083 |
| 64 | Hypoplasia of the fovea (HP:0007750) | 2.55396083 |
| 65 | Shallow orbits (HP:0000586) | 2.54136833 |
| 66 | Hemiparesis (HP:0001269) | 2.52093792 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.52061846 |
| 68 | Oligomenorrhea (HP:0000876) | 2.51118991 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.51021121 |
| 70 | Diplopia (HP:0000651) | 2.51021121 |
| 71 | Shawl scrotum (HP:0000049) | 2.49470657 |
| 72 | Nasolacrimal duct obstruction (HP:0000579) | 2.48055007 |
| 73 | Abnormality of chloride homeostasis (HP:0011422) | 2.46342740 |
| 74 | Aortic aneurysm (HP:0004942) | 2.44865858 |
| 75 | Abnormality of the foot musculature (HP:0001436) | 2.43985100 |
| 76 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.43876723 |
| 77 | Hemangiomatosis (HP:0007461) | 2.43775793 |
| 78 | Spinal rigidity (HP:0003306) | 2.43289931 |
| 79 | Heart block (HP:0012722) | 2.40905155 |
| 80 | Abnormality of the astrocytes (HP:0100707) | 2.36747882 |
| 81 | Astrocytoma (HP:0009592) | 2.36747882 |
| 82 | Action tremor (HP:0002345) | 2.35823816 |
| 83 | Ventricular tachycardia (HP:0004756) | 2.34216156 |
| 84 | Resting tremor (HP:0002322) | 2.32848653 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.32763352 |
| 86 | Nuclear cataract (HP:0100018) | 2.30633149 |
| 87 | Abnormality of the pulmonary veins (HP:0011718) | 2.30443263 |
| 88 | Sudden death (HP:0001699) | 2.29664752 |
| 89 | Atrioventricular block (HP:0001678) | 2.28745798 |
| 90 | Abnormality of chromosome segregation (HP:0002916) | 2.27294252 |
| 91 | Aplasia involving bones of the extremities (HP:0009825) | 2.26683953 |
| 92 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.26683953 |
| 93 | Aplasia of the phalanges of the hand (HP:0009802) | 2.26683953 |
| 94 | Embryonal renal neoplasm (HP:0011794) | 2.25227551 |
| 95 | Exercise-induced muscle cramps (HP:0003710) | 2.24083655 |
| 96 | Difficulty climbing stairs (HP:0003551) | 2.23658297 |
| 97 | Neck muscle weakness (HP:0000467) | 2.22893990 |
| 98 | EMG: myopathic abnormalities (HP:0003458) | 2.21510507 |
| 99 | Rhabdomyosarcoma (HP:0002859) | 2.21314307 |
| 100 | Hypopigmentation of the fundus (HP:0007894) | 2.20878751 |
| 101 | Abnormal eating behavior (HP:0100738) | 2.15581230 |
| 102 | Hypertriglyceridemia (HP:0002155) | 2.13330269 |
| 103 | Polar cataract (HP:0010696) | 2.12278123 |
| 104 | Papilledema (HP:0001085) | 2.11248640 |
| 105 | Tetany (HP:0001281) | 2.10321312 |
| 106 | Abnormality of the fovea (HP:0000493) | 2.09433307 |
| 107 | Hypercortisolism (HP:0001578) | 2.08609924 |
| 108 | Abnormality of magnesium homeostasis (HP:0004921) | 2.07942468 |
| 109 | Atrial fibrillation (HP:0005110) | 2.06860313 |
| 110 | EMG: neuropathic changes (HP:0003445) | 2.06174974 |
| 111 | Ketoacidosis (HP:0001993) | 2.04387865 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 2.04012057 |
| 113 | Myotonia (HP:0002486) | 2.03138042 |
| 114 | Broad face (HP:0000283) | 2.02260290 |
| 115 | Abnormality of the pubic bones (HP:0003172) | 2.00591167 |
| 116 | Annular pancreas (HP:0001734) | 2.00575720 |
| 117 | Upper limb amyotrophy (HP:0009129) | 2.00277416 |
| 118 | Distal upper limb amyotrophy (HP:0007149) | 2.00277416 |
| 119 | Bulbar palsy (HP:0001283) | 1.99074544 |
| 120 | Horizontal nystagmus (HP:0000666) | 1.98552293 |
| 121 | Prolonged QT interval (HP:0001657) | 1.98011915 |
| 122 | Sensory axonal neuropathy (HP:0003390) | 1.97999422 |
| 123 | Abnormality of glycine metabolism (HP:0010895) | 1.96582640 |
| 124 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.96582640 |
| 125 | Muscle fiber inclusion bodies (HP:0100299) | 1.96122514 |
| 126 | Focal motor seizures (HP:0011153) | 1.95954235 |
| 127 | Abnormality of the periventricular white matter (HP:0002518) | 1.94755399 |
| 128 | Primary atrial arrhythmia (HP:0001692) | 1.92911282 |
| 129 | Postural instability (HP:0002172) | 1.92899883 |
| 130 | Rectovaginal fistula (HP:0000143) | 1.91593103 |
| 131 | Rectal fistula (HP:0100590) | 1.91593103 |
| 132 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91483138 |
| 133 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.91029239 |
| 134 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90452233 |
| 135 | Syncope (HP:0001279) | 1.90097731 |
| 136 | Vaginal fistula (HP:0004320) | 1.89984563 |
| 137 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.89931813 |
| 138 | Truncal ataxia (HP:0002078) | 1.89642734 |
| 139 | Focal seizures (HP:0007359) | 1.89376937 |
| 140 | Bifid tongue (HP:0010297) | 1.89224817 |
| 141 | Supraventricular arrhythmia (HP:0005115) | 1.87322591 |
| 142 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.86601560 |
| 143 | Onion bulb formation (HP:0003383) | 1.86553960 |
| 144 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.85982413 |
| 145 | Hemorrhage of the eye (HP:0011885) | 1.85837462 |
| 146 | Broad metatarsal (HP:0001783) | 1.85645534 |
| 147 | Bradycardia (HP:0001662) | 1.85433199 |
| 148 | Frequent falls (HP:0002359) | 1.84661862 |
| 149 | Abnormality of the nasal mucosa (HP:0000433) | 1.83782986 |
| 150 | Hypoplasia of the iris (HP:0007676) | 1.83725158 |
| 151 | Hypoalbuminemia (HP:0003073) | 1.83722802 |
| 152 | Abnormal albumin level (HP:0012116) | 1.83722802 |
| 153 | Supraventricular tachycardia (HP:0004755) | 1.83590248 |
| 154 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83447126 |
| 155 | Large earlobe (HP:0009748) | 1.82882522 |
| 156 | Colitis (HP:0002583) | 1.82669513 |
| 157 | Dysmetria (HP:0001310) | 1.82617550 |
| 158 | Turricephaly (HP:0000262) | 1.81965315 |
| 159 | Round ear (HP:0100830) | 1.81163575 |
| 160 | Periauricular skin pits (HP:0100277) | 1.81010904 |
| 161 | Preauricular pit (HP:0004467) | 1.81010904 |
| 162 | Polygenic inheritance (HP:0010982) | 1.80655178 |
| 163 | Abnormality of the musculature of the hand (HP:0001421) | 1.80538310 |
| 164 | Supernumerary nipples (HP:0002558) | 1.79983203 |
| 165 | Intestinal fistula (HP:0100819) | 1.79958750 |
| 166 | Rapidly progressive (HP:0003678) | 1.79793224 |
| 167 | Short humerus (HP:0005792) | 1.79233667 |
| 168 | Ventricular arrhythmia (HP:0004308) | 1.79073744 |
| 169 | Right ventricular cardiomyopathy (HP:0011663) | 1.79047611 |
| 170 | Nemaline bodies (HP:0003798) | 1.78832876 |
| 171 | Aneurysm (HP:0002617) | 1.76236937 |
| 172 | Neuronal loss in central nervous system (HP:0002529) | 1.75422236 |
| 173 | Preauricular skin tag (HP:0000384) | 1.74912336 |
| 174 | Abnormality of the lacrimal duct (HP:0011481) | 1.74871340 |
| 175 | Focal segmental glomerulosclerosis (HP:0000097) | 1.74732278 |
| 176 | Cervical subluxation (HP:0003308) | 1.74250933 |
| 177 | Back pain (HP:0003418) | 1.73687883 |
| 178 | Muscle stiffness (HP:0003552) | 1.73636396 |
| 179 | Ventricular fibrillation (HP:0001663) | 1.72412056 |
| 180 | Hyperacusis (HP:0010780) | 1.70938588 |
| 181 | Rigidity (HP:0002063) | 1.70781831 |
| 182 | Sleep apnea (HP:0010535) | 1.70299464 |
| 183 | Spastic gait (HP:0002064) | 1.69025031 |
| 184 | Growth hormone excess (HP:0000845) | 1.67984543 |
| 185 | Lower limb muscle weakness (HP:0007340) | 1.67710286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.31010357 |
| 2 | GRK5 | 3.93090726 |
| 3 | ERN1 | 3.64996858 |
| 4 | GRK1 | 3.13725656 |
| 5 | GRK6 | 3.10113672 |
| 6 | TGFBR2 | 3.07069278 |
| 7 | TIE1 | 2.76032418 |
| 8 | WNK4 | 2.64782280 |
| 9 | TYRO3 | 2.49890231 |
| 10 | WNK1 | 2.44867010 |
| 11 | OXSR1 | 2.40592015 |
| 12 | MAPK7 | 2.18868587 |
| 13 | ADRBK2 | 2.03302547 |
| 14 | SIK1 | 1.94538836 |
| 15 | MARK2 | 1.91400730 |
| 16 | DAPK2 | 1.89974409 |
| 17 | NTRK1 | 1.85653049 |
| 18 | MAP3K13 | 1.79819131 |
| 19 | CSF1R | 1.78597114 |
| 20 | GRK7 | 1.76008992 |
| 21 | STK39 | 1.72840453 |
| 22 | KDR | 1.64208470 |
| 23 | MATK | 1.59557809 |
| 24 | MAP3K7 | 1.53705973 |
| 25 | CAMK4 | 1.52030311 |
| 26 | UHMK1 | 1.49194905 |
| 27 | PAK4 | 1.47857027 |
| 28 | RIPK1 | 1.45675745 |
| 29 | TRIB3 | 1.45149386 |
| 30 | PHKG2 | 1.43289395 |
| 31 | PHKG1 | 1.43289395 |
| 32 | PRKG2 | 1.42348947 |
| 33 | WNK3 | 1.41751724 |
| 34 | LATS2 | 1.41631130 |
| 35 | RIPK4 | 1.39069640 |
| 36 | LMTK2 | 1.37842534 |
| 37 | MARK1 | 1.31075217 |
| 38 | ARAF | 1.27808968 |
| 39 | MAPK12 | 1.27580798 |
| 40 | MAP3K9 | 1.27448388 |
| 41 | STK10 | 1.26766988 |
| 42 | MAP3K6 | 1.24597627 |
| 43 | MOS | 1.23052364 |
| 44 | CAMKK1 | 1.22864943 |
| 45 | KSR2 | 1.15562222 |
| 46 | EPHA4 | 1.15345079 |
| 47 | FGFR3 | 1.15123391 |
| 48 | SIK2 | 1.12049511 |
| 49 | CDC42BPA | 1.10792858 |
| 50 | TESK1 | 1.07491489 |
| 51 | EEF2K | 1.06362934 |
| 52 | MUSK | 1.02768789 |
| 53 | ADRBK1 | 1.01953722 |
| 54 | CAMK2B | 0.99202884 |
| 55 | EPHB1 | 0.97725577 |
| 56 | PDGFRA | 0.94833129 |
| 57 | PRKD3 | 0.94172834 |
| 58 | OBSCN | 0.94048642 |
| 59 | HIPK2 | 0.93878538 |
| 60 | TTK | 0.87289025 |
| 61 | EPHB2 | 0.85172700 |
| 62 | MAP3K1 | 0.82553203 |
| 63 | RPS6KA2 | 0.82027995 |
| 64 | MAPKAPK3 | 0.81433600 |
| 65 | TNIK | 0.80797982 |
| 66 | STK38 | 0.79460719 |
| 67 | MAP3K11 | 0.77685102 |
| 68 | CAMK2G | 0.76253822 |
| 69 | EPHA2 | 0.75638769 |
| 70 | BMX | 0.75171421 |
| 71 | AKT2 | 0.74916307 |
| 72 | SGK2 | 0.74687482 |
| 73 | CDK5 | 0.73610856 |
| 74 | FES | 0.71602847 |
| 75 | MAP2K4 | 0.70881026 |
| 76 | NTRK2 | 0.68517958 |
| 77 | RET | 0.67477121 |
| 78 | PRPF4B | 0.67273258 |
| 79 | CSK | 0.64134070 |
| 80 | PRKD2 | 0.63752403 |
| 81 | MAPK10 | 0.63529369 |
| 82 | DDR2 | 0.62725618 |
| 83 | TBK1 | 0.62651761 |
| 84 | TTN | 0.61255555 |
| 85 | PRKD1 | 0.59906886 |
| 86 | ROCK1 | 0.59508870 |
| 87 | PDGFRB | 0.58970337 |
| 88 | CDK7 | 0.58314640 |
| 89 | CAMK1 | 0.57507015 |
| 90 | TRPM7 | 0.56132153 |
| 91 | PTK2 | 0.54411728 |
| 92 | PRKAA2 | 0.54219128 |
| 93 | PTK6 | 0.54191782 |
| 94 | PAK6 | 0.54024401 |
| 95 | PAK3 | 0.53884418 |
| 96 | MINK1 | 0.52766520 |
| 97 | MAPK15 | 0.52298273 |
| 98 | PRKCH | 0.51231141 |
| 99 | ROCK2 | 0.50949018 |
| 100 | PINK1 | 0.50309258 |
| 101 | STK11 | 0.49710613 |
| 102 | MST1R | 0.49372749 |
| 103 | FGFR4 | 0.49339213 |
| 104 | CAMK1D | 0.48873357 |
| 105 | FER | 0.48823318 |
| 106 | IGF1R | 0.48751056 |
| 107 | RPS6KL1 | 0.48184069 |
| 108 | RPS6KC1 | 0.48184069 |
| 109 | AKT3 | 0.47595792 |
| 110 | ZAP70 | 0.46953387 |
| 111 | PRKAA1 | 0.46125449 |
| 112 | MET | 0.45688442 |
| 113 | RPS6KA3 | 0.45353713 |
| 114 | JAK1 | 0.43610842 |
| 115 | GSK3A | 0.41509057 |
| 116 | MYLK | 0.40701488 |
| 117 | SGK223 | 0.40666843 |
| 118 | SGK494 | 0.40666843 |
| 119 | BCKDK | 0.40652620 |
| 120 | ALK | 0.40638173 |
| 121 | DMPK | 0.40411990 |
| 122 | PDK2 | 0.37460519 |
| 123 | MAP2K6 | 0.36701903 |
| 124 | MTOR | 0.36388350 |
| 125 | PDK3 | 0.36093569 |
| 126 | PDK4 | 0.36093569 |
| 127 | NTRK3 | 0.36071732 |
| 128 | SIK3 | 0.35141272 |
| 129 | PDK1 | 0.34735360 |
| 130 | SRC | 0.34630907 |
| 131 | ICK | 0.34310193 |
| 132 | SGK3 | 0.33617256 |
| 133 | PTK2B | 0.32234104 |
| 134 | INSR | 0.31964489 |
| 135 | TNK2 | 0.31728033 |
| 136 | PDPK1 | 0.29973434 |
| 137 | PRKACG | 0.29713896 |
| 138 | CAMK1G | 0.28980303 |
| 139 | MAPK4 | 0.28734258 |
| 140 | PKN1 | 0.28595227 |
| 141 | PRKACB | 0.28373351 |
| 142 | PRKACA | 0.28203045 |
| 143 | MARK3 | 0.26088537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.45406713 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.23209780 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.61288152 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.34122881 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03614735 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.93563102 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.92132780 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85485427 |
| 9 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80568270 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.66095118 |
| 11 | * Long-term potentiation_Homo sapiens_hsa04720 | 1.61135244 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.58423425 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.57294783 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 1.55590207 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54894759 |
| 16 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.50752400 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47776965 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.45032723 |
| 19 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44554486 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43876708 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42009695 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38146298 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34728573 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.31438503 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.30920048 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28738158 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.27790140 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.27632168 |
| 29 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25426357 |
| 30 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23792724 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.23640631 |
| 32 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.21716344 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21383485 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19329023 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18003789 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17693149 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.17476229 |
| 38 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.14818214 |
| 39 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14201159 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13924614 |
| 41 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.12885462 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10104997 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09539086 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.05681791 |
| 45 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.05460009 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05266413 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04994399 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02745652 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02289121 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 1.02275087 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02107252 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.01116829 |
| 53 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01017615 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.01004687 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00978883 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 1.00196878 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98292730 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97890627 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97674510 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96576860 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 0.96256830 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.95620070 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95049253 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93318268 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.92481709 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91654360 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90277304 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.89880516 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89467802 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88717266 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88587500 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87246555 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86694217 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.86347472 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85566832 |
| 76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85020616 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84403063 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84324433 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.82399530 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.82207724 |
| 81 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82189587 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81482497 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80788984 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80656669 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80384226 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79005108 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78566043 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.78438765 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78084358 |
| 90 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77444652 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76977899 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76974837 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76968951 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.76137543 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.74305753 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71659685 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71290943 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70790051 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70168623 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69502415 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.68746081 |
| 102 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68217572 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68141519 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67458790 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67414896 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.65719876 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65182387 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64729387 |
| 109 | Tight junction_Homo sapiens_hsa04530 | 0.64632885 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.64453297 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63106066 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62439926 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61542450 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60468605 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59841017 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56533988 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56281938 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.56221446 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.55157015 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54561077 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53660178 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53467760 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53125344 |
| 124 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51609785 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51403060 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51281740 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50759526 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50639937 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50554799 |
| 130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50322906 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50091370 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49705857 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.49441031 |
| 134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49169542 |
| 135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48586993 |
| 136 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48437975 |
| 137 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48419936 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.47922011 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47386036 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45537078 |
| 141 | Gap junction_Homo sapiens_hsa04540 | 0.45082829 |
| 142 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44729686 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44652734 |
| 144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44327406 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.43632032 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41829652 |

